Confluent, Inc.

**Signal Note: Eventide Initiates CFLT Position** Eventide's $770K entry into Confluent (data streaming infrastructure) is notable given the firm's biotech-focused mandate—suggesting conviction that CFLT's event-streaming platform is critical infrastructure for biotech/pharma data workflows (clinical trials, real-world evidence, regulatory submissions). This positioning aligns with broader industry shift toward real-time data architectures in drug development and post-market surveillance, though the signal lacks immediate catalyst visibility tied to specific pipeline or approval events.